Forced expiratory volume in one second: Prognostic value in systolic heart failure

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1573-1574

  Miniati, Massimo ^a   Monti, Simonetta ^b   Bottai, Matteo ^c,d   Passino, Claudio ^b,e   Emdin, Michele ^b   Poletti, Roberta ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CNR   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Heart failure; Lung dysfunction; Spirometry

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; HEMOGLOBIN; NORADRENALIN;

AGE DISTRIBUTION; AGED; BODY MASS; CARDIOMEGALY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATIONAL STUDY; DIAPHRAGM DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOVENTILATION; LETTER; LUNG EDEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RESTRICTIVE VENTILATORY IMPAIRMENT; SLOW VITAL CAPACITY; SPIROMETRY; SURVIVAL RATE; SYSTOLIC HEART FAILURE;

HEART FAILURE; LUNG DYSFUNCTION; SPIROMETRY;

AGED; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84885314528     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.170     Document Type: Article

References (10)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Developed In collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESiCM). Eur Heart J 2008;29:2388-442.
2. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009;11:130-9.
3. Iversen KK, Kjaergaard J, Akkan D, et al. The prognostic Importance of lung function In patients admitted with heart failure. Eur J Heart Fail 2010;12:685-91.
4. McKee PA, CastelliWP, McNamara PM, KannelWB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
5. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
6. Naum CC, Sciurba FC, Rogers RM. Pulmonary function abnormalities In chronic severe cardiomyopathy preceding heart transplantation. Am Rev Respir Dis 1992;145:1334-8.
7. Meyer FJ, BorstMM, Zugck C, et al. Respiratorymuscle dysfunction In congestive heart failure: clinical correlation and prognostic significance. Circulation 2001;103:2153-8.
8. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
9. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
10. Hawkins NM, Petrie MC, McDonald MR, et al. Heart failure and chronic obstructive pulmonary disease. The quandary of beta-blockers and beta-agonists. J Am Coll Cardiol 2011;57:2127-38.